Your browser doesn't support javascript.
loading
Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients.
Rogado, J; Sánchez-Torres, J M; Romero-Laorden, N; Ballesteros, A I; Pacheco-Barcia, V; Ramos-Leví, A; Arranz, R; Lorenzo, A; Gullón, P; Donnay, O; Adrados, M; Costas, P; Aspa, J; Alfranca, A; Mondéjar, R; Colomer, R.
Afiliação
  • Rogado J; Medical Oncology Department, Instituto de Investigación Sanitaria la Princesa, HU La Princesa, Madrid, Spain.
  • Sánchez-Torres JM; Medical Oncology Department, Instituto de Investigación Sanitaria la Princesa, HU La Princesa, Madrid, Spain.
  • Romero-Laorden N; Medical Oncology Department, Instituto de Investigación Sanitaria la Princesa, HU La Princesa, Madrid, Spain.
  • Ballesteros AI; Medical Oncology Department, Instituto de Investigación Sanitaria la Princesa, HU La Princesa, Madrid, Spain.
  • Pacheco-Barcia V; Medical Oncology Department, Instituto de Investigación Sanitaria la Princesa, HU La Princesa, Madrid, Spain.
  • Ramos-Leví A; Endocrinology Department, Instituto de Investigación Sanitaria la Princesa, HU La Princesa, Madrid, Spain.
  • Arranz R; Hematology Department, HU la Princesa, Madrid, Spain.
  • Lorenzo A; Hematology Department, HU la Princesa, Madrid, Spain.
  • Gullón P; Social and Cardiovascular Epidemiology Research Group, Alcalá University, Madrid, Spain.
  • Donnay O; Medical Oncology Department, Instituto de Investigación Sanitaria la Princesa, HU La Princesa, Madrid, Spain.
  • Adrados M; Pathology Department, Instituto de Investigación Sanitaria La Princesa, HU la Princesa, Madrid, Spain.
  • Costas P; Medical Oncology Department, Instituto de Investigación Sanitaria la Princesa, HU La Princesa, Madrid, Spain.
  • Aspa J; Neumology Department, Instituto de Investigación Sanitaria La Princesa, HU la Princesa, Madrid, Spain.
  • Alfranca A; Immunology Department, Instituto de Investigación Sanitaria la Princesa, Madrid, Spain.
  • Mondéjar R; Medical Oncology Department, Instituto de Investigación Sanitaria la Princesa, HU La Princesa, Madrid, Spain.
  • Colomer R; Medical Oncology Department, Instituto de Investigación Sanitaria la Princesa, HU La Princesa, Madrid, Spain. Electronic address: rcolomer@seom.org.
Eur J Cancer ; 109: 21-27, 2019 03.
Article em En | MEDLINE | ID: mdl-30682533
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Nivolumabe / Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Nivolumabe / Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2019 Tipo de documento: Article